Stifel Financial Corp Acquires Shares of 16,883 Esperion Therapeutics, Inc.

Stifel Financial Corp Acquires Shares of 16,883 Esperion Therapeutics, Inc.

Stifel Financial Corp acquired a new position in Esperion Therapeutics, Inc. during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission . The firm acquired 16,883 shares of the biopharmaceutical company's stock, valued at approximately $601,000.

from Biotech News